Cancer Immunotherapy Winter School

Attend the Cancer Immunotherapy Winter School

New Comprehensive Cancer Immunotherapy Program Provides Advanced Training

Join the Society for Immunotherapy of Cancer (SITC) for this comprehensive cancer immunotherapy program, in Mesa, Ariz., Feb. 18–22, 2019. Taught by leading experts, this five-day program will provide attendees a deep understanding of the core principles of tumor immunology and cancer immunotherapy and examine developing areas in the field.

Developed specifically to instruct future scientists and clinicians, the program will first cover the fundamentals of cancer immunotherapy before allowing participants to tailor their experience by selecting the track most relevant to their educational goals.

Over the course of the week, attendees will learn about:

Core principles of tumor immunology and cancer immunotherapy
Biomarker technology, validation and clinical integration
Clinical trial design, data analysis and considerations for combination therapies
Grant writing to obtain research funding

As attendees deepen their understanding, they will also benefit from professional development while interacting with faculty and thought leaders in this intimate setting.

Program ORGANIZERS

Lisa H. Butterfield, PhD – University of Pittsburgh
Leisha A. Emens, MD, PhD – University of Pittsburgh
Michael A. Morse, MD – Duke University Medical Center

Who should attend?

Graduate students, postdoctoral fellows and clinical fellows in the field of cancer immunotherapy
Individuals new to the field working in academic, clinical, industry and government settings

Program Schedule

5-Day Program Days 1 & 2 – Basic tumor immunology and cancer immunotherapy topics Days 3, 4, & 5 – In-depth topics with multi-track structure
February 18, 2019 (Basic Immunology at Play in Tumor Immunology)
8-8:30 a.m.	Breakfast
8:30-9 a.m.	Welcome from Program Directors
9-10 a.m.	Topic 1 – Immunotherapy Overview: History of the Field Michael T. Lotze, MD - University of Pittsburgh
10-10:10 a.m.	Break
10:10-11:10 a.m.	Topic 2 – Biomarker Basics, Current Biomarkers (PD-L1, MSI, TMB) Priti S. Hegde, PhD - Genentech
11:10 a.m.-12:10 p.m.	Topic 3 – Adaptive Immunity: Cellular Mechanisms and Signaling Stephen Schoenberger, PhD—La Jolla Institute for Allergy and Immunology
12:10-1 p.m.	Lunch – Roundtables with Faculty 1
1-2 p.m.	Topic 4 – Tumor biology: Cellular Mechanisms and Signaling
2-3 p.m.	Topic 5 – Tumor Immunosuppression Mechanisms Greg M. Delgoffe, PhD—University of Pittsburgh
3-3:15 p.m.	Break
3:15-4:15 p.m.	Topic 6 – Tumor Microenvironment: How Tumors and Immunity Interact
4:15-5:15 p.m.	Breakout Sessions 1: Topic A – Antigen Presentation Topic B – T Cell Exhaustion Greg M. Delgoffe, PhD—University of Pittsburgh Topic C – Emerging Biomarkers Priti S. Hegde, PhD - Genentech

February 19, 2019 (Translational Cancer Immunotherapy)
8-9 a.m.	Breakfast – Roundtables with Faculty 2
9-10 a.m.	Topic 7 – Immunotherapeutic strategy: Immune Checkpoint Blockade
10-10:10 a.m.	Break
10:10-11:10 a.m.	Topic 8 – Immunotherapeutic strategy: Adoptive Cell and CAR T Therapies
11:10 a.m.-12:10 p.m.	Topic 9 – Immunotherapeutic Strategy: Vaccines and Neoantigens Lisa H. Butterfield, PhD - University of Pittsburgh
12:10-1 p.m.	Lunch – Roundtables with Faculty 3
1-2 p.m.	Topic 10 – Innate Immunity: Cellular Mechanisms and Signaling Lewis Lanier, PhD - University of California, San Francisco
2-3 p.m.	Topic 11 – Methods to Assess and Discover Biomarkers Priti S. Hegde, PhD - Genentech
3-3:15 p.m.	Break
3:15-4:15 p.m.	Topic 12 – Immunity and Therapeutic Efficacy Jerome Galon, PhD - Universite Pierre Et Marie Curie, Sorbonne Universites
4:15-5:15 p.m.	Breakout Sessions 2: Topic D – Cytokine-Based Immunotherapies and Other Molecular Bispecifics, Other Immunotherapies Michael T. Lotze, MD - University of Pittsburgh Topic E – Other Targetable Immune Pathways of Interest Hussein A. Tawbi, MD, PhD— University of Texas, MD Anderson Cancer Center Topic F – Dendritic/NK Cell Mechanisms Lewis Lanier, PhD - University of California, San Francisco

February 20, 2019 (In-Depth Education)
7:30-8 a.m.	Continental Breakfast
8-9 a.m.	Topic 1 for all Attendees: Grantsmanship Mary L. Disis, MD - University of Washington
9-10 a.m.	Topic 2 for all Attendees: Presenting Your Data
10-10:10 a.m.	Break
10:10-11:10 a.m.	Breakout 1: Researchers Topic 1 – Transcriptional Profiling Ena Wang, MD - Allogene Clinicians Topic 1 – Phase I Immunotherapy Clinical Trials Michael A. Morse, MD - Duke University Medical Center
11:10 a.m.-12:10 p.m.	Breakout 2: Researchers Topic 2 – Protein Characterization Victor H. Engelhard, PhD - University of Virginia School of Medicine Clinicians Topic 2 – Phase II Immunotherapy Clinical Trials Daniel P. Normolle, PhD - University of Pittsburgh
12:10-1 p.m.	Lunch
1-2 p.m.	Breakout 3: Researchers Topic 3 – Pre-Clinical Animal Models Karolina Palucka, MD, PhD - The Jackson Laboratory for Genomic Medicine Clinicians Topic 3 – Phase III Immunotherapy Clinical Trials Leisha A. Emens, MD, PhD - University of Pittsburgh
2-3 p.m.	Breakout 4: Researchers Topic 4 – Tumor Cell Analyses Jerome Galon, PhD - Universite Pierre Et Marie Curie, Sorbonne Universites Clinicians Topic 4 – Biomarker Testing in Clinical Trials Lisa H. Butterfield, PhD - University of Pittsburgh
3-3:15 p.m.	Break
3:15-4:15 p.m.	Small Group Work/Hands on Session with Faculty: Topic 1 – Case Studies Topic 2 – Development of Individualized Translational Grant/Idea Topic 3 – Faculty Ideas for Hands-On Learning Topic 4 – Industry-Led Session: New Agents Ginna G. Laport, MD - Tempest Therapeutics

February 21, 2019 (In-Depth Education)
7:30-8 a.m.	Continental Breakfast
8-9 a.m.	Topic 3 for all attendees: Data and Statistical Analyses: Tips and Tricks Daniel P. Normolle, PhD - University of Pittsburgh
9-9:10 a.m.	Break
9:10-10:10 a.m.	Breakout 5: Researchers Topic 5: How to Handle Big/High-Throughput Data Leslie Cope, PhD - Johns Hopkins School of Medicine Clinicians Topic 5: Autoimmunity and irAEs Michael A. Morse, MD - Duke University Medical Center
10:10-11:10 a.m.	Breakout 6: Researchers Topic 6: Computational Biology/Machine Learning Takis Benos, PhD - University of Pittsburgh Clinicians Topic 6: Biomarker-Based Clinical Trials Hussein Tawbi, MD, PhD— University of Texas, MD Anderson Cancer Center
11:10 a.m.-12:10 p.m.	Topic 4 for all Attendees: MSI High and Biomarker-Based Trials
12:10-1 p.m.	Lunch
1-2 p.m.	Breakout 7: Researchers Topic 7: New Genetic Techniques Kole Roybal, PhD - University of California, San Francisco Clinicians Topic 7: Immunotherapy in Special Patient Populations Michael A. Morse, MD - Duke University Medical Center
2-3 p.m.	Breakout 8: Researchers Topic 8: Pre-Clinical Combination Immunotherapy Karolina Palucka, MD, PhD - The Jackson Laboratory for Genomic Medicine Clinicians Topic 8: Clinical Combination Immunotherapy Leisha A. Emens, MD, PhD - University of Pittsburgh
3-3:15 p.m.	Break
3:15-4:15 p.m.	Small Group Work/Hands on Session with Faculty: Topic 1 – Case Studies Topic 2 – Development of Individualized Translational Grant/Idea Mary L. Disis, MD - University of Washington Topic 3 – Faculty Ideas for Hands-on Learning Topic 4 – Industry-Led Session: New Biomarkers

February 22, 2019 (In-Depth Education)
7:30-8 a.m.	Continental Breakfast
8-9 a.m.	Topic 5 for all attendees: FDA Perspective on Immunotherapy Raj K. Puri, MD, PhD - Food and Drug Administration
9-10 a.m.	Topic 6 for all Attendees: Regulatory Submissions/INDs/RAC Submissions Raj K. Puri, MD, PhD - Food and Drug Administration
10-10:10 a.m.	Break
10:10-11:10 a.m.	Breakout 9: Researchers Topic 9 – Translating Research Into the Clinic: What Is GMP? Lisa H. Butterfield, PhD - University of Pittsburgh Clinicians Topic 9 – Clinical Endpoints Michael A. Morse, MD - Duke University Medical Center
11:10 a.m.-12:10 p.m.	Breakout 10: Researchers Topic 10 – Clinical Trial Basics Decoded Leisha A. Emens, MD, PhD - University of Pittsburgh Clinicians Topic 10 – Patient Monitoring/Education
12:10-1 p.m.	Lunch
1-2 p.m.	Small Group Work/Hands on Session with Faculty: Topic 1 – Case Studies Topic 2 – Development of Individualized Translational Grant/Idea Topic 3 – Faculty Ideas for Hands-on Learning Topic 4 – Industry-led Session: Careers in Industry Ginna G. Laport, MD - Tempest Therapeutics
2-2:10 p.m.	Break
2:10-3:10 p.m.	Topic 7 for all Attendees: Perspective on Direction of the Field Francesco Marincola, MD, FACS - Refuge Consulting

Cancer Immunotherapy Winter School Travel Awards

SITC will distribute a limited number of travel awards for the SITC Cancer Immunotherapy Winter School. Awards will cover travel, accommodations and registration. Applicants must submit an applicant statement of purpose, curriculum vitae, proof of dates of student/fellow status, and a letter of recommendation to Rebecca Borzon, rborzon@sitcancer.org.

Travel award applications close Monday, Nov. 12^th. Notifications will be sent by early January. More information on eligibility requirements and how to apply can be found here.

Feb. 18–22, 2019

Register Now

Registration Rates

Delta Hotels Phoenix Mesa
200 North Centennial Way
Mesa, Ariz. 85201

Please make your hotel reservation using the “Reserve Your Hotel Room” button below.

Receive the discounted rate of $169 per night (offered to registered attendees).

Reserve your room by Jan. 25, 2019.

RESERVE YOUR HOTEL ROOM